| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.1 | 0.06 |